Silver Jubilee of HER2 targeting: a clinical success in breast cancer

In the last century, scientists have discovered that when human epidermal growth factor receptor 2 (HER2) is overexpressed or amplified—found in approximately 15 %–20 % of breast cancer patients—it significantly increases the risk of tumor recurrence and metastasis. This crucial discovery has made a...

Full description

Saved in:
Bibliographic Details
Main Authors: Jianli Zhao, Ziyue Zhou, Phei Er Saw, Erwei Song
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Journal of the National Cancer Center
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667005425000195
Tags: Add Tag
No Tags, Be the first to tag this record!